BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28119454)

  • 1. Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma.
    Song H; Lin C; Yao E; Zhang K; Li X; Wu Q; Chuang PT
    J Biol Chem; 2017 Mar; 292(9):3888-3899. PubMed ID: 28119454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid C-Cell Biology and Oncogenic Transformation.
    Cote GJ; Grubbs EG; Hofmann MC
    Recent Results Cancer Res; 2015; 204():1-39. PubMed ID: 26494382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RREB1 promotes the development of parafollicular carcinogenesis through the Ras-Raf-1-ELK3 signaling pathway.
    Ma S; Wang H; Li W; Yan Z; Luo X; Lu P
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):972-981. PubMed ID: 35737446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology of C Cells and Medullary Thyroid Carcinoma.
    Schmid KW
    Recent Results Cancer Res; 2015; 204():41-60. PubMed ID: 26494383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Medullary Thyroid Carcinoma Arise in Thyroglossal Duct Cysts? A Search for Parafollicular C-cells in 41 Resected Cases.
    Stein T; Murugan P; Li F; El Hag MI
    Head Neck Pathol; 2018 Mar; 12(1):71-74. PubMed ID: 28536894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of primary and mature transcripts of calcitonin-gene-related peptide genes in rat parafollicular cells by light, fluorescence and confocal microscopy.
    van Lieshout EM; Hougaard DM; Larsson LI
    Histochem Cell Biol; 1995 Jan; 103(1):19-24. PubMed ID: 7736276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a novel cell line of medullary thyroid carcinoma from a dog.
    Okano K; Uematsu Y; Nibe K; Yamashita M; Suzuki S; Uchida K; Ono K; Hirao H
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):559-566. PubMed ID: 31144267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid.
    Hirsch MS; Faquin WC; Krane JF
    Mod Pathol; 2004 Jun; 17(6):631-6. PubMed ID: 15098009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Wang Y; Du LL; Hou SH; Han CZ; Zhao XW; Wang WG; Xu XQ; Jing JX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Nov; 51(11):873-876. PubMed ID: 27938622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PREOPERATIVE DIAGNOSTICS OF THYROID MEDULLARY CARCINOMA WITH EMPHASIS ON CYTOMORPHOLOGICAL FEATURES AND DIFFERENTIAL DIAGNOSIS OF PRIMARY AND SECONDARY THYROID TUMORS].
    Katović SK; Vasilj A
    Acta Med Croatica; 2014 Dec; 68(4-5):383-8. PubMed ID: 26285471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.
    Nakagawa T; Mabry M; de Bustros A; Ihle JN; Nelkin BD; Baylin SB
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5923-7. PubMed ID: 3112776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma.
    Macià A; Gallel P; Vaquero M; Gou-Fabregas M; Santacana M; Maliszewska A; Robledo M; Gardiner JR; Basson MA; Matias-Guiu X; Encinas M
    Oncogene; 2012 Aug; 31(35):3961-72. PubMed ID: 22158037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
    Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of follicular cells on calcitonin gene expression in thyroid parafollicular cells in cell culture.
    Zabel M; Dietel M; Gebarowska E; Michael R
    Histochem J; 1999 Mar; 31(3):175-80. PubMed ID: 10421417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
    Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
    Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity.
    Nakazawa T; Cameselle-Teijeiro J; Vinagre J; Soares P; Rousseau E; Eloy C; Sobrinho-Simões M
    Int J Surg Pathol; 2014 Sep; 22(6):530-5. PubMed ID: 24599901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-situ analysis of calcitonin and CGRP expression in medullary thyroid carcinoma.
    Boultwood J; Wynford-Thomas D; Richards GP; Craig RK; Williams ED
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):381-90. PubMed ID: 2253409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.
    Baloch ZW; LiVolsi VA
    Turk Patoloji Derg; 2015; 31 Suppl 1():60-79. PubMed ID: 26177318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.
    Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
    J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.